Global Information
회사소개 | 문의 | 비교리스트

세계의 인플루엔자 진단 시장 : 검사 유형별(기존 진단(RIDT, 직접 형광 항체, 바이러스 배양, 혈청), 분자진단별(Time RT-PCR, INAAT(NASBA, LAMP))), 최종사용자별(병원, 검사실, 교육기관 등) 예측(-2027년)

Influenza Diagnostics Market by Test Type {[Traditional (RIDT, Direct Fluorescent Antibody, Viral Culture, Serology), Molecular [RT-PCR, INAAT (NASBA, LAMP)]}, End User (Hospitals, Laboratories, Academics, & Others)-Global Forecast to 2027

리서치사 Meticulous Market Research Pvt. Ltd.
발행일 2020년 06월 상품 코드 942393
페이지 정보 영문 169 Pages
가격
US $ 3,975 ₩ 4,697,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄는 1회에 한해 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,175 ₩ 8,479,000 PDF by E-mail (Multi User License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄는 5회에 한해 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 인플루엔자 진단 시장 : 검사 유형별(기존 진단(RIDT, 직접 형광 항체, 바이러스 배양, 혈청), 분자진단별(Time RT-PCR, INAAT(NASBA, LAMP))), 최종사용자별(병원, 검사실, 교육기관 등) 예측(-2027년) Influenza Diagnostics Market by Test Type {[Traditional (RIDT, Direct Fluorescent Antibody, Viral Culture, Serology), Molecular [RT-PCR, INAAT (NASBA, LAMP)]}, End User (Hospitals, Laboratories, Academics, & Others)-Global Forecast to 2027
발행일 : 2020년 06월 페이지 정보 : 영문 169 Pages

세계의 인플루엔자 진단 시장은 2019-2027년간 7.9%의 연평균 복합 성장률(CAGR)로 성장하여 2027년까지 11억 7,000만 달러 규모에 달할 것으로 예상되고 있습니다. 시장 성장 주요인으로서 인플루엔자 유병률 증가, 조기 발견에 대한 의식 고양, CLIA-waived POC 분자 인플루엔자 검사 개발, 중앙 검사실에서 PoC 방식으로의 초점 전환 등을 들 수 있습니다. 또한 신흥시장(인도, 브라질, 중국 등)이 전세계 벤더에게 큰 성장 기회를 제공하고 있습니다.

세계의 인플루엔자 진단(Influenza Diagnostics) 시장에 대해 분석했으며, 시장의 기본 구조, 주요 시장 성장 촉진요인 및 억제요인. 전반적인 시장 동향 전망(과거 2년간, 향후 7년간), 검사 유형별·최종사용자별·지역별 상세 동향, 최근의 시장 경쟁 및 자본거래 동향, 주요 기업 프로파일 등의 정보를 전해드립니다.

제1장 서론

제2장 조사 방법

제3장 개요

제4장 시장 인사이트

  • 서론
  • 시장 성장 촉진요인
    • 인플루엔자의 세계적인 유행
    • 인플루엔자 조기 진단에 대한 의식 고양
    • CLIA-waived POC 분자 인플루엔자 검사 개발
    • 검사 서비스 : 중앙 검사실에서 PoC 방식으로의 전환
  • 시장 성장 억제요인
    • 중-고도 복잡성 테스트의 기술 요건과 규제 프로세스
  • 시장 기회
    • 유전체학과 단백질체학의 진보
    • 신흥경제에서의 성장 기회
  • 과제
    • 불리하고 부족한 상환 시나리오
  • 코로나19(Covid-19)의 영향

제5장 세계의 인플루엔자 진단 시장 : 검사 유형별

  • 서론
  • 기존 진단 검사
    • 인플루엔자 신속 진단 테스트(RIDT)
    • 직접 형광 항체(DFA) 검사
    • 바이러스 배양
    • 혈청 분석
  • 분자진단 검사
    • 역전사 중합효소 연쇄반응(RT-PCR)
    • 등온 핵산증폭시험(INAAT)
    • 기타 분자진단 검사

제6장 세계의 인플루엔자 진단 시장 : 최종사용자별

  • 서론
  • 병원/임상검사실
  • 표준 실험실
  • 교육기관/연구기관
  • 기타 최종사용자

제7장 세계의 인플루엔자 진단 시장 : 지역별

  • 서론
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 기타 유럽 국가
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 기타 아시아태평양 국가
  • 라틴아메리카
  • 중동 및 아프리카

제8장 경쟁 환경

  • 서론
  • 주요 성장 전략
  • 기업간 비교 분석
  • 시장 점유율 분석(2019년)
    • F. Hoffmann-La Roche Ltd
    • Quidel Corporation
    • Thermo Fisher Scientific, Inc.
    • Abbott Laboratories
    • 기타 기업

제9장 기업 개요(사업 개요, 주요 재무비율, 제품 포트폴리오, 전략 전개 상황)

  • Thermo Fisher Scientific, Inc.
  • Abbott Laboratories
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • BioMerieux SA
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • Hologic, Inc.
  • Siemens Healthineers AG (Subsidiary of Siemens AG)
  • Luminex Corporation
  • GenMark Diagnostics, Inc.
  • Altona Diagnostics GmbH
  • SA Scientific, Ltd.
  • Sekisui Diagnostics, LLC
  • CorisBioconcept SPRL
  • ELITech Group
  • Mast Group, Ltd.
  • Response Biomedical Corporation
  • Germaine Laboratories, Inc.

제10장 부록

LSH 20.07.07

List of Tables

  • Table 1 Global Influenza Diagnostics Market Drivers: Impact Analysis (2020-2027)
  • Table 2 Europe: Percentage of Specimens Positive for Influenza, 2015-2020
  • Table 3 Global Influenza Diagnostics Market Restraint: Impact Analysis (2020-2027)
  • Table 4 Some Clinical Applications of Influenza Genomics and Proteomics
  • Table 5 COVID 19 Confirmed Cases and Deaths across the World (27th May 2020)
  • Table 6 Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($ Million)
  • Table 7 Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 8 Traditional Influenza Diagnostic Tests Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 9 Advantages & Disadvantages of RIDT
  • Table 10 RIDTs Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 11 Direct Fluorescent Antibody Tests Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 12 Viral Culture Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 13 Serological Assays Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 14 Molecular Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 15 Molecular Influenza Diagnostic Tests Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 16 Comparison of RT-PCR with Traditional Diagnostic Tests
  • Table 17 RT-PCR Tests Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 18 INAAT Based Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 19 INAAT Based Influenza Diagnostics Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 20 Loop-Mediated Isothermal Amplification (Lamp) Assays Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 21 Transcription Mediated Isothermal Based Amplification Assays Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 22 Nucleic Acid Sequence-Based Amplification Tests Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 23 Other INAAT Assays Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 24 Other Molecular Influenza Diagnostic Tests Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 25 Influenza Diagnostics Market Size, by End User, 2018-2027 ($ Million)
  • Table 26 Influenza Diagnostics Market Size for Hospital & Clinical Laboratories, by Country/Region, 2018-2027 ($ Million)
  • Table 27 Influenza Diagnostics Market Size for Diagnostic Reference Laboratories, by Country/Region, 2018-2027 ($Million)
  • Table 28 Influenza Diagnostics Market Size for Academics/Research Institutes, by Country/Region, 2018-2027 ($Million)
  • Table 29 Influenza Diagnostics Market Size for Other End Users, by Country/Region, 2018-2027 ($Million)
  • Table 30 Influenza Diagnostics Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 31 North America: Influenza Diagnostics Market Size, by Country, 2018-2027 ($Million)
  • Table 32 North America: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 33 North America: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 34 North America: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 35 North America: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 36 North America: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 37 U.S.: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 38 U.S.: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 39 U.S.: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 40 U.S.: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 41 U.S.: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 42 Canada: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 43 Canada: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 44 Canada: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 45 Canada: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 46 Canada: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 47 Europe: Influenza Diagnostics Market Size, by Country, 2018-2027 ($Million)
  • Table 48 Europe: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 49 Europe: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 50 Europe: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 51 Europe: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 52 Europe: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 53 Germany: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 54 Germany: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 55 Germany: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 56 Germany: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 57 Germany: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 58 France: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 59 France: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 60 France: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 61 France: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 62 France: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 63 Number of Acute Respiratory Illness Outbreaks in the U.K. by Institution Type: 2015-2019
  • Table 64 U.K.: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 65 U.K.: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 66 U.K.: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 67 U.K.: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 68 U.K.: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 69 Italy: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 70 Italy: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 71 Italy: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 72 Italy: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 73 Italy: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 74 Spain: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 75 Spain: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 76 Spain: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 77 Spain: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 78 Spain: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 79 Rest of Europe: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 80 Rest of Europe: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 81 Rest of Europe: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 82 Rest of Europe: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 83 Rest of Europe: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 84 Asia-Pacific: Influenza Diagnostics Market Size, by Country, 2018-2027 ($Million)
  • Table 85 Asia-Pacific: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 87 Asia-Pacific: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 88 Asia-Pacific: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 89 Asia-Pacific: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 90 China: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 91 China: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 92 China: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 93 China: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 94 China: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 95 Japan: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 96 Japan: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 97 Japan: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 98 Japan: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 99 Japan: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 100 India: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 101 India: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 102 India: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 103 India: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 104 India: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 105 Rest of Asia-Pacific: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 106 Rest of Asia-Pacific: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 107 Rest of Asia-Pacific: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 108 Rest of Asia-Pacific: Isothermal Nucleic Acid Amplification Tests Market Size, 2018-2027 ($Million)
  • Table 109 Rest of Asia-Pacific: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 110 Latin America: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 111 Latin America: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 112 Latin America: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 113 Latin America: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 114 Latin America: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 115 Middle East & Africa: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 116 Middle East & Africa: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 117 Middle East & Africa: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 118 Middle East & Africa: Isothermal Nucleic Acid Amplification Tests Market Size, 2018-2027 ($Million)
  • Table 119 Middle East & Africa: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 120 Recent Developments, by Company, 2017-2020

List of Figures

  • Figure 1 Key Stakeholders
  • Figure 2 Research Process
  • Figure 3 Key Secondary Sources
  • Figure 4 Primary Research Techniques
  • Figure 5 Key Executives Interviewed
  • Figure 6 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
  • Figure 7 Market Size Estimation
  • Figure 8 Global Influenza Diagnostics Market, by Test Type, 2020 Vs 2027 ($Million)
  • Figure 9 Global Influenza Diagnostics Market Overview, by End User, 2020-2027 ($Million)
  • Figure 10 Regional Snapshot: Influenza Diagnostics Market
  • Figure 11 Market Dynamics
  • Figure 12 Global Influenza Transmission Zone
  • Figure 13 U.S. Influenza Burden (2010-2018)
  • Figure 14 Global Influenza Diagnostics Market Size, by Test Type, 2020-2027 ($Million)
  • Figure 15 Global Influenza Diagnostics Market Size, by End User, 2020-2027 ($Million)
  • Figure 16 Global Influenza Diagnostics Market Size, by Geography, 2020-2027 ($Million)
  • Figure 17 North America: Influenza Diagnostics Market Snapshot
  • Figure 18 Population Aged 65 or above (As % of total Population) in the U.S.:2012-2018
  • Figure 19 Europe: Influenza Diagnostics Market Snapshot
  • Figure 20 Healthcare Spending Per Capita in France: 2015-2018
  • Figure 21 Proportion of Population Aged 65 or Above (As % of total Population)
  • Figure 22 Influenza Cases in Spain per 100,000 Inhabitants: 2015-2019
  • Figure 23 Per Capita Health Spending by Country, 2018 ($)
  • Figure 24 Asia-Pacific: Influenza Diagnostics Snapshot
  • Figure 25 Number of Geriatric Population (Aged 65 & Above) In China: 2010-2050(In Millions)
  • Figure 26 Number of Swine Flu Cases in India: 2012-2018
  • Figure 27 Population Aged 60 & Above In Latin America: 2000-2050 (In Millions)
  • Figure 28 Key Growth Strategies Adopted by Leading Players, 2017-2020
  • Figure 29 Influenza Diagnostics Market: Competitive Benchmarking
  • Figure 30 Global Influenza Diagnostics Market Share Analysis, by Key Players, 2019 (%)
  • Figure 31 thermo Fisher Scientific, Inc.: Financial Overview (2019)
  • Figure 32 Abbott Laboratories: Financial Overview (2019)
  • Figure 33 Danaher Corporation: Financial Overview (2019)
  • Figure 34 Bio-Rad Laboratories, Inc.: Financial Overview (2019)
  • Figure 35 BioMerieux S.A.: Financial Overview (2018)
  • Figure 36 F. Hoffmann-La Roche Ltd: Financial Overview (2019)
  • Figure 37 Becton, Dickinson and Company: Financial Overview (2019)
  • Figure 38 Meridian Bioscience, Inc.: Financial Overview (2019)
  • Figure 39 Quidel Corporation: Financial Overview (2019)
  • Figure 40 Hologic, Inc.: Financial Overview (2019)
  • Figure 41 Siemens Healthineers Ag: Financial Overview (2019)
  • Figure 42 Luminex Corporation: Financial Overview (2019)
  • Figure 43 GenMark Diagnostics, Inc.: Financial Overview (2019)

Title:
Influenza Diagnostics
by Test Type {[Traditional (RIDT, Direct Fluorescent Antibody, Viral Culture, Serology), Molecular [RT-PCR, INAAT (NASBA, LAMP)]}, End User (Hospitals, Laboratories, Academics, Research Institutes)-Global Forecast to 2027.

The influenza diagnostics market is expected to grow at a CAGR of 7.9% from 2020 to 2027 to reach $1.17 billion by 2027.

The growth in the influenza diagnostics market is mainly attributed to the factors such as increasing prevalence of influenza, growing awareness for early detection using specific diagnostic tests, development of CLIA-waived POC molecular influenza tests, and shifting focus from centralized laboratories to decentralized point-of-care testing. In addition, advances in genomics and proteomics and emerging markets such as India, Brazil, China, and other countries provide significant growth opportunities for vendors present across the globe.

To provide efficient analysis, Meticulous Research® has segmented this market by test type (traditional diagnostic tests, molecular diagnostic tests), end user (hospital & clinical laboratories, diagnostic reference laboratories, academic/research institutes, and others), and geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).

Based on test type, the traditional diagnostic tests segment is estimated to account for the largest share of the overall influenza diagnostics market in 2020. The large share of this segment is primarily attributed to the wide use of rapid influenza diagnostics tests (RIDTs) due to its cost-effectiveness and ability to provide test results in 15- 30 minutes. In addition, the availability of advanced diagnostic immunoassay formats and increasing usage of miniaturized devices in influenza diagnostics are further stimulating the growth of this segment. However, the molecular diagnostic tests segment is expected to grow at the fastest growth rate during the forecast period.

Based on end user, the diagnostic reference laboratories segment is projected to register the fastest CAGR during the forecast period, mainly due to their nature of supporting the diagnosis required in patient care as well as medical research. Moreover, owing to curtailed reimbursements for laboratory testing services, hospitals prefer to outsource their diagnostic testing services to the large commercial laboratories and eliminate associated operational expenses required for maintaining in-house labs, thereby driving the market.

An in-depth analysis of the geographic scenario of the influenza diagnostics market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. North America region is estimated to dominate the global influenza diagnostics market in 2020, followed by Europe, and Asia Pacific. The factors such as increasing incidence of influenza, higher adoption for technologically advanced diagnostic products, and increase in the research and development activities for influenza supported the largest share of the North America region in the influenza diagnostics market.

The key players operating in the global influenza diagnostics market are Thermo Fisher Scientific Inc. (U.S.), Hologic, Inc. (U.S.), Quidel Corporation (U.S.), F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), Meridian Bioscience Inc. (U.S.),bioMerieux SA (France), Luminex Corporation (U.S.), Siemens Healthineers AG (Germany), GenMark Diagnostics, Inc. (U.S.), Sekisui Diagnostics, LLC (U.S.), altona Diagnostics GmbH (Germany), SA Scientific, Ltd. (U.S.), and ELITech Group (France), Coris Bioconcept SPRL (Belgium), and Mast Group Ltd.(U.K.), among others.

Scope of the Report:

Market by Test Type

  • Traditional Diagnostic Tests
    • Rapid influenza diagnostic tests (RIDTs
    • Direct Fluorescent Antibody (DFA) Tests
    • Viral Culture
    • Serological Assays
  • Molecular Diagnostic Tests
    • Reverse Transcription Polymerase Chain Reaction (RT-PCR)
    • Isothermal Nucleic Acid Amplification Tests (INAAT)
    • Loop Mediated Isothermal Based Amplification Assays
    • Transcription Mediated Isothermal Based Amplification Assays
    • Transcription Mediated Isothermal Based Amplification Assays
    • Other Isothermal Nucleic Acid Amplification Tests
    • Other Molecular Diagnostic Tests

Market by End User

  • Hospitals & Clinical Laboratories
  • Diagnostic Reference Laboratories
  • Academic/Research Institutes
  • Others

Market by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
      • 2.3.1.1. Bottom-Up Approach
      • 2.3.1.2. Top-Down Approach
      • 2.3.1.3. Growth forecast
    • 2.3.2. Market Share Analysis
  • 2.4. Assumptions for the Study
  • 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Market Overview
  • 4.2. Drivers
    • 4.2.1. Increasing Global Prevalence of Influenza
    • 4.2.2. Growing Awareness of Early Influenza Diagnosis
    • 4.2.3. Development of CLIA-Waived POC Molecular Influenza Tests
    • 4.2.4. Shift in Focus from Centralized Laboratories to Point-of-Care Testing Services
  • 4.3. Restraints
    • 4.3.1. Technical Requirements and Regulatory Process for High or Moderate Complexity Tests
  • 4.4. Opportunities
    • 4.4.1. Advances in Genomics and Proteomics
    • 4.4.2. Growth Opportunities in Emerging Economies
  • 4.5. Challenges
    • 4.5.1. Unfavorable and Inadequate Reimbursement Scenario
  • 4.6. Impact of Covid-19 Pandemic

5. Global Influenza Diagnostics Market, by Test Type

  • 5.1. Introduction
  • 5.2. Traditional Diagnostic Tests
    • 5.2.1. Rapid Influenza Diagnostics Test (RIDT)
    • 5.2.2. Direct Fluorescent Antibody (DFA) Tests
    • 5.2.3. Viral Culture
    • 5.2.4. Serological Assays
  • 5.3. Molecular Diagnostic Tests
    • 5.3.1. Reverse Transcription Polymerase Chain Reaction (RT-PCR)
    • 5.3.2. Isothermal Nucleic Acid Amplification Tests (INAAT)
      • 5.3.2.1. Loop Mediated Isothermal Based Amplification Assays
      • 5.3.2.2. Transcription Mediated Isothermal Based Amplification Assays
      • 5.3.2.3. Nucleic Acid Sequence-Based Amplification Tests
      • 5.3.2.4. Other Isothermal Nucleic Acid Amplification Assays
    • 5.3.3. Other Molecular Diagnostic Tests

6. Global Influenza Diagnostics Market, by End User

  • 6.1. Introduction
  • 6.2. Hospital & Clinical Laboratories
  • 6.3. Diagnostic Reference Laboratories
  • 6.4. Academic/Research Institutes
  • 6.5. Other End Users

7. Global Influenza Diagnostics Market, by Geography

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. U.S.
    • 7.2.2. Canada
  • 7.3. Europe
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Rest of Europe
  • 7.4. Asia-Pacific
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. India
    • 7.4.4. Rest of Asia-Pacific
  • 7.5. Latin America
  • 7.6. Middle East & Africa

8. Competitive Landscape

  • 8.1. Introduction
  • 8.2. Key Growth Strategies
  • 8.3. Competitive Benchmarking
  • 8.4. Market Share Analysis (2019)
    • 8.4.1. F. Hoffmann-La Roche Ltd
    • 8.4.2. Quidel Corporation
    • 8.4.3. Thermo Fisher Scientific, Inc.
    • 8.4.4. Abbott Laboratories
    • 8.4.5. Other Companies

9. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments)

  • 9.1. Thermo Fisher Scientific, Inc.
  • 9.2. Abbott Laboratories
  • 9.3. Danaher Corporation
  • 9.4. Bio-Rad Laboratories, Inc.
  • 9.5. BioMerieux S.A.
  • 9.6. F. Hoffmann-La Roche Ltd.
  • 9.7. Becton, Dickinson and Company
  • 9.8. Meridian Bioscience, Inc.
  • 9.9. Quidel Corporation
  • 9.10. Hologic, Inc.
  • 9.11. Siemens Healthineers AG (Subsidiary of Siemens AG)
  • 9.12. Luminex Corporation
  • 9.13. GenMark Diagnostics, Inc.
  • 9.14. Altona Diagnostics GmbH
  • 9.15. SA Scientific, Ltd.
  • 9.16. Sekisui Diagnostics, LLC
  • 9.17. CorisBioconcept SPRL
  • 9.18. ELITech Group
  • 9.19. Mast Group, Ltd.
  • 9.20. Response Biomedical Corporation
  • 9.21. Germaine Laboratories, Inc.

10. Appendix

  • 10.1. Questionnaire
  • 10.2. Available Customization
Back to Top
전화 문의
F A Q